Selasa, 29 Mei 2012

Bone Loss May Be Detectable Earlier, NASA

Bone Loss May Be Detectable Earlier, NASA

Featured Article
Academic Journal
Main Category: Bones / Orthopedics
Also Included In: Medical Devices / Diagnostics;  Cancer / Oncology
Article Date: 29 May 2012 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article


Patient / Public:not yet rated

Healthcare Prof:not yet rated


Scientists from NASA and Arizona State University (ASU) in the US have developed a new way of detecting bone loss that promises to be safer and capable of earlier diagnosis than current methods that rely on X-rays. They write about their work in a study due to published in PNAS this week.

Osteoporosis, where loss of bone causes bones to grow weaker, threatens more than half of the over-50s in the US. Bone loss also occurs in the advanced stages of some types of cancer.

Senior author Ariel Anbar is a professor in ASU's Department of Chemistry and Biochemistry and the School of Earth and Space Exploration. He told the press:

"By the time these changes can be detected by X-rays, as a loss of bone density, significant damage has already occurred."

"Also, X-rays aren't risk-free. We think there might be a better way," he added.

NASA is interested in this type of research because astronauts in microgravity also experience bone loss.

The new method that Anbar and colleagues have developed relies on detecting tiny changes in calcium isotopes that are naturally present in urine.

Patients do not need to ingest artificial tracers and are not exposed to radiation, so there is virtually no risk, say the researchers.

The new technique relies on the fact that different isotopes of calcium react at slightly different rates. When bones form, the lighter isotopes enter new bone a little faster than the heavier ones, a difference called "isotope fractionation".

Bone is not "dead", inert material but living tissue that is continuously undergoing formation and destruction. In healthy, active humans, these processes are in balance, but a disease can upset this balance, causing a shift in the isotope ratios.

Corresponding author Joseph Skulan, an adjunct professor at ASU, combined all the factors that influence this balance into a mathematical model that predicted calcium isotope ratios in blood and urine should be very sensitive to bone mineral balance.

The predicted effect is so small it has to be measured using sensitive mass spectrometry methods specially developed at ASU.

For the NASA-funded study, the researchers tested urine samples of a dozen healthy volunteers who were confined to "bed rest" for 30 days.

When a person lies down for a prolonged period, their weight-bearing bones, such as those in the legs and spine, experience "skeletal unloading" as a result of their loss of burden.

During skeletal unloading, bones start to deteriorate as the balance between bone generation and bone destruction tips more toward destruction. Extended periods of bed rest result in bone loss similar to that seen in patients with osteoporosis and astronauts.

When they analyzed the urine samples, the researchers found the new technique could spot the early signs of bone loss after just one week of bed rest, long before changes in bone density can be detected using the conventional method of dual-energy X-ray absorptiometry (DEXA).

Another important feature of the new technique is that it is the only method, apart from DEXA, that measures net bone loss directly.

First author Jennifer Morgan, whose doctoral work at ASU focused on developing the mass spectrometry method, said:

"What we really want to know is whether the amount of bone in the body is increasing or decreasing."

The team is now working on a way to evaluate the technique in samples from cancer patients.

Anbar said their study is a "proof of concept", and their paper in PNAS shows "the concept works as expected in healthy people in a well-defined experiment. The next step is to see if it works as expected in patients with bone-altering diseases."

"That would open the door to clinical applications," he added.

The researchers note that the technique can be applied to many other diseases that cause subtle changes in isotope balance or in the concentration of elements.

These kinds of signatures have not yet been explored in a systematic way as potential biosignatures for detecting cancers and other diseases, they said.

The "concept of inorganic signatures" promises to bring in an "entirely new generation of diagnostics for cancer and other diseases", says Anna Barker, former deputy director of the National Cancer Institute, who is now director of Transformative Healthcare Networks and co-director of the Complex Adaptive Systems Initiative in the Office of Knowledge Enterprise Development at ASU.

Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Bone Loss May Be Detectable Earlier, NASA'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network back to top | home | privacy policy

MediLexicon International Ltd Logo MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Tidak ada komentar:

Posting Komentar